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8 The Journal of Thoracic and Cardiovbjective: We sought to analyze the effect of patent ductus arteriosus diameter on
reatment success in premature neonates.
ethods: Among 537 consecutive neonates born between 1985 and 2005 with a
iagnosed patent ductus arteriosus, 201 premature patients (35 weeks’ gestation)
reated for a hemodynamically significant patent ductus arteriosus were retrospec-
ively reviewed. Two groups were compared: group MED (n  154; successful
reatment with indomethacin) and group FAIL (n  47; failure of medication to
educe the patent ductus arteriosus diameter to hemodynamic insignificance).
esults: After unsuccessful medical treatment, 33 patients required surgical patent
uctus arteriosus closure, 12 died before further possible treatment, and 2 were
ischarged home without clinical symptoms but with an open patent ductus arteri-
sus. Mean patent ductus arteriosus diameter in the FAIL group (2.8 0.9 mm) was
ignificantly larger than that in the MED group (2.4  0.6 mm, P  .01). Assisted
espiration time (ventilation plus continuous positive airway pressure) before patent
uctus arteriosus closure was longer in the FAIL group (20 days) than in the MED
roup (9 days, P  .001) but was similar after patent ductus arteriosus closure. By
sing an index of patent ductus arteriosus diameter squared/birth weight (in square
illimeters per kilogram), a cutoff value of less than 9 mm2/kg correctly predicts
edical patent ductus arteriosus closure in 87.5% of patients. Values of greater than
mm2/kg correctly predict medication failure in 41.5% of patients.
onclusions: In preterm babies requiring surgical patent ductus arteriosus closure,
onger respiration times reflect a delay while attempting medical treatment, but
espiration time is equally short between groups after shunt elimination. Medical
reatment, although a valid first option, is likely to fail with larger patent ductus
rteriosus diameters and lower birth weights. Unwarranted assisted respiration and
orresponding hospital stay might be shortened by earlier surgical referral for patent
uctus arteriosus closure in preterm babies with a patent ductus arteriosus index of
reater than 9 mm2/kg.
rematurity increases the risk for patent ductus arteriosus (PDA).1,2 In ex-
tremely premature neonates (gestational age 26 weeks), the incidence of
PDA has been reported to be as high as 30% to 67%.3,4 The left-to-right shunt
aused by the PDA results in increased pulmonary blood flow and a steal from the
ystemic circulation. This might jointly be responsible for further comorbidities
ssociated with PDA,5 such as chronic lung disease,6 intraventricular hemorrhage,4
ecrotizing enterocolitis,7 or retinopathy.8 Early closure of the PDA has been shown
o improve both cardiorespiratory status and long-term follow-up.9 Conservative
reatment includes a stepwise initiation of fluid restriction,1 continuous positive
irway pressure respiratory assistance, intubation, and mechanical ventilation with
ascular Surgery ● January 2008
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Decrease in inspiratory time and application of positive
nd-expiratory pressure, and cyclooxygenase inhibitors.3
inally, when medical treatment fails, the PDA can be
igated surgically,8,10 but the optimal timing is still highly
ebatable. Outcomes, intensive care and hospital stay, costs
nvolved, and sparse follow-up data raise the question of the
ptimal treatment algorithm for a hemodynamically signif-
cant PDA.
We reviewed our experience from the last 2 decades with
his lesion and hypothesized that earlier surgical interven-
ion to close the larger PDA would be safe and an alterna-
ive to predictable prior medical failure.
aterials and Methods
ermission to proceed with this study was granted by the Institu-
ional Review Board of our Children’s Hospital. Between January
985 and December 2005, 537 consecutive premature neonates
35 weeks’ gestation) with a diagnosed PDA were born in the
linic of Neonatology of the University Hospital or referred to the
ivision of Neonatology at the University Children’s Hospital.
rom this cohort, 201 babies were medically treated with prosta-
landin synthetase inhibitors (indomethacin) for a hemodynami-
ally significant PDA and constitute the study group. Nine neo-
ates presented either with contraindications to medical treatment
r with hemodynamic instability, so as to preclude an attempt at
edical closure, and went directly to surgical PDA ligation; these
re not included in this analysis. Two groups were defined: the
ED group with 154 (77%) babies treated successfully with
ndomethacin and the FAIL group with 47 (23%) babies in whom
edication failed to reduce the PDA diameter to hemodynamic
nsignificance. The FAIL group includes 33 patients who eventu-
lly required surgical ligation of the PDA, 12 neonates who died
efore surgical closure of the PDA, and 2 infants with a hemody-
amically significant PDA but without clinical symptoms at the
ime of hospital discharge.
Hemodynamic significance was diagnosed either clinically or
y means of echocardiographic analysis. Since 1996, echocardi-
graphy is routine in all premature babies in both study hospitals.
chocardiographic criteria for hemodynamic significance were
ilatation of the left atrium (left atrium/aortic root ratio 1.5), as
easured by means of M-mode scanning, and a pandiastolic
etrograde flow from the ductus into the descending aorta. Mea-
urements of the PDA considered the minimal diameter of the
uctus in the black-and-white 2-dimensional cross-section image
rom a high-parasternal long-axis view. Before the echocardio-
raphic era, clinical criteria included a systolic or continuous
achinery murmur, bounding pulses, a clearly amplified precor-
ium, and systemic hypotension.
The indication for medical treatment was weight dependent.
or neonates weighing less then 1250 g, echocardiographic diag-
Abbreviation and Acronym
PDA patent ductus arteriosusosis of a PDA was enough to start medical treatment, irrespective e
The Journal of Thoracf hemodynamic significance. Babies weighing more than 1250 g
eeded to have either clinical symptoms or an echocardiographi-
ally proved significance of the PDA to indicate medical treatment.
reatment entailed 0.2 mg/kg intravenous indomethacin every 12
ours for 3 doses in the 1980s or 0.1 mg · kg1 · d1 for 6 days
ince then.
The criteria for surgical PDA ligation were failure of complete
edical treatment or hemodynamic instability during ongoing but
ncomplete medical treatment. Surgical intervention was per-
ormed after achievement of general anesthesia and endotracheal
ntubation. The chest was entered through a muscle-sparing left
osterolateral thoracotomy. The third intercostal space was en-
ered, and the PDA was either ligated or clipped.
General patient demographics included gestational age, birth
ength and weight, sex, comorbidities (ie, chronic lung disease,
ntraventricular hemorrhage, necrotizing enterocolitis, and retinop-
thy), duration of intensive care unit stay, and length of hospital-
zation. Chronic lung disease was defined as oxygen dependence
fter 36 days of life with an initial gestational age of less than 32
eeks or oxygen dependence after 28 days of life with a gesta-
ional age of greater than 32 weeks. Data recorded before PDA
losure included age and weight at closure, PDA diameter, left
trium/aortic root ratio, and the time of assisted respiration (con-
inuous positive airway pressure time plus mechanical ventilation
ime) before closure. Data recorded after PDA closure included
ime of assisted respiration after closure, the echocardiographic
onfirmation of PDA closure, and postsurgical complications (chy-
othorax, recurrent laryngeal nerve damage, coarctation, iatrogenic
igation of the aorta, and pneumothorax).
Statistical analysis was performed by using logistic regression
o compare the MED and FAIL groups with respect to continuous
ariables. This allowed us to use the same statistical method for
oth univariate analyses (testing for the significance of the rela-
ionship between 1 continuous variable, such as PDA diameter or
irth weight, and the outcome) and multivariate analyses (testing
or the joint influence of 2 variables, such as PDA diameter and
irth weight, on the outcome). The Fisher exact test was used to
ompare both groups in terms of comorbidities. Continuous vari-
bles are presented as means and standard deviations.
esults
he PDA diameter was significantly smaller in the MED
roup (2.4  0.6 mm) than that in the FAIL group (2.8 
.9 mm, P  .006). Birth weight was larger in the MED
roup (1.1 0.3 kg) than in the FAIL group (1.1 0.3 kg),
ithout reaching statistical significance (P  .22). In a
ultivariate analysis including both variables as predictors,
he PDA diameter remained significant (P  .002), and
irth weight was almost significant (P  .07). Looking for
n index or ratio by using a measurable baseline patient
haracteristic that could help to predict outcome, we calcu-
ated the logistic regression of the logarithms of PDA di-
meter and birth weight. The regression coefficients were
.209 and 1.111, respectively. Because the amplitude of
he former is about twice the amplitude of the latter, this
uggested consideration of an index defined as “PDA diam-
ter squared/birth weight” to predict the outcome.
ic and Cardiovascular Surgery ● Volume 135, Number 1 79
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DIn our sample 87.5% of patients in the MED group had
value of less than 9 mm2/kg, at which medical treatment
ppropriately achieved PDA closure. By using this cutoff
alue, only 12.5% of the MED group had a value of greater
han 9 mm2/kg and would have inappropriately been sent
irectly to surgical intervention without a prior medical trial
false-positive result). On the other hand, 41.5% of the
atients in the FAIL group had an index of greater than 9
m2/kg and could have benefited from direct surgical re-
igure 1. Scatter plot of all patients from both groups depicting
he relationship between PDA diameter squared and weight at
irth. PDA, Persistent ductus arteriosus.
ABLE 1. Characteristics of the 2 groups
Successful medical c
MED group (n  1
DA diameter 2.4 (0.6); n 88
irth weight (kg) 1.1 (0.3)
A/Ao ratio 1.57 (0.26); n 1
notropes 30 (64%)
hronic lung disease 44 (29%)
radycardia-apnea syndrome 118 (77%)
ntraventricular hemorrhage 43 (28%)
ecrotizing enterocolitis 13 (8%)
etinopathy 33 (21%)
eans (standard deviation) are shown for continuous variables, and coun
S, not significant; LA/Ao, left atrium/aortic root.
0 The Journal of Thoracic and Cardiovascular Surgery ● Januaerral, without wasting time for indomethacin failure, if this
ndex is validated. The cutoff value at 9 mm2/kg might
epresent a useful value for predicting in which patients the
edical treatment will succeed and which patients should
robably undergo surgical intervention rapidly after an ini-
ial medical trial (Figure 1).
As described in Table 1, the preoperative left atrium/aortic
oot ratio was significantly smaller in the MED group (1.57
.26) compared with that in the FAIL group (1.72 0.39, P
01). The comorbidities associated with PDA (chronic lung
isease, intraventricular hemorrhage, necrotizing enteroco-
itis, or retinopathy) were comparable in both groups. When
pecifically considering the 33 surgically treated infants of
he FAIL group compared with those of the MED group,
here is a significant difference with regard to chronic lung
isease: 16 (48%) of 33 versus 44 (29%) of 154 in the MED
roup (P  .05). Importantly, there was a significant dif-
erence in the amount of infants receiving preoperative
notropes, with 29% in the MED group compared with 64%
n the FAIL group (P .001). This illustrates the number of
atients in an unstable hemodynamic condition who either
ake it to surgical intervention or die before surgical clo-
ure is possible (12/47 [25.5%]; Table 1).
Comparison between the assisted respiration and hospi-
alization times of the 2 groups is depicted in Table 2.
ssisted respiration time before PDA closure was signifi-
antly (P  .001) shorter in the MED group (9  7.2 days)
han in the FAIL group (20  14 days). There was no
ignificant difference in assisted respiration time after PDA
losure between the groups (MED group, 12  13.2 days;
AIL group, 11  14.9 days). The time spent in the inten-
ive care unit differed significantly between the 2 groups
MED group: 21  15.1 days vs FAIL group: 34  30.8
ays, P .001). The MED group had a significantly (P .01)
horter hospitalization time (75  33.8 days) than the FAIL
roup (100  35.1 days). When counting only the time of
ospitalization after the PDA was closed, there was no signif-
e, Failed medical closure,
FAIL group (n  47) P value
2.8 (0.9); n 41 .01
1.1 (0.3) NS (.069)
1.72 (0.39); n 36 .01
44 (29%) .001
16 (34%) NS
29 (62%) NS
17 (36%) NS
9 (19%) NS
10 (21%) NS
rcentage) are shown for binary variables. PDA, Patent ductus arteriosus;losur
54)
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Dcant difference between the 2 groups (MED group: 64  33.1
ays vs FAIL group: 69  37.3 days, Table 2).
The overall mortality was 14%. There was a significant
ifference in mortality between the 2 groups (8% [13/154]
n the MED group and 34% [16/47] in the FAIL group, P 
001). Comparing only the surgically treated infants from
he FAIL group (4/33 [12%]) with the MED group, there
as no significant difference in mortality. The mortality of
urgically treated neonates who underwent surgical inter-
ention without a prior medical trial because of contraindi-
ations or hemodynamic instability was 11% (1/9). Among
ll surgical patients, there was 1 postoperative chylothorax
nd 1 recurrent nerve paresis.
iscussion
n premature neonates, a PDA is a common and potentially
ife-threatening condition.1,10-14 and early closure of a PDA
mproves cardiorespiratory status.9 Medical and technologic
dvances have improved the survival of preterm infants,
hus extending the limits of viability.12 Common treatment
f a PDA is a stepwise escalation and begins with cycloox-
genase inhibitors, although protocols in centers vary
trongly with regard to patient selection and when and how
o treat them.13 The indication for surgical intervention is
sually given when medical treatment fails,15-18 when there
re contraindications to medication, or in the face of hemo-
ynamic instability despite inotropic support.7 In the ab-
ence of these settings, no study has demonstrated clear
ndications for earlier “elective” surgical referral, predicting
favorable outcome. In their series of 197 premature infants
ndergoing PDA ligation, Raval and colleagues15 reported
reater gestational age, older age, larger size, and lesser
entilatory support at the time of surgical intervention to be
ssociated with better outcomes, although they found no
bsolute cutoff values.
Early surgical closure, compared with ligation performed
t a later stage, is associated with improved short-term
entilatory parameters and pulmonary function, more rapid
chievement of full oral feeding, and improved body
rowth.11,14 In our series there was a higher tendency to-
ard comorbidities in the FAIL group compared with the
ED group. More specifically, when considering only the
ABLE 2. Respiration and hospitalization times in the 2 gr
Successful
MED gro
espiration time before PDA closure (d) 9
espiration time after PDA closure (d) 12
otal hospitalization time (d) 75
ospitalization time after PDA closure (d) 64
ata are presented as means (standard deviation). PDA, Patent ductus aurgical group, the incidence of preoperative chronic lung m
The Journal of Thoracisease was significantly more increased compared with that
n the MED group. It is only speculative to think that earlier
DA closure with direct surgical referral of neonates having an
ndex of greater than 9 mm2/kg would reduce the incidence of
hronic lung disease through reduced assisted respiration times
nd intensive care stay. Indeed, other groups have demon-
trated that delaying surgical ligation might increase the like-
ihood of morbidity, mortality, or both.17,18
We found relatively rapid improvements in pulmonary
unction after surgical PDA closure, with postclosure as-
isted respiration times similar to those after medical treat-
ent, despite the longer preoperative and total assisted
espiration times, higher inotrope requirements, and longer
ntensive care unit stays with potential iatrogenic complica-
ions in the group of patients who underwent surgical inter-
ention. This would argue in favor of early shunt elimina-
ion, with its beneficial effect on lung function. Contrary to
ur findings, Raval and colleagues15 did not observe rapid
mprovements in cardiorespiratory status, with a significant
ortion of patients going on to have chronic lung disease,
ven after shunt elimination. Nonetheless, they do not ad-
ocate delaying surgical closure and find no contraindica-
ions to attempt PDA ligation, regardless of how small,
remature, or unstable the patient’s status preoperatively.
The significant difference in mortality between the 2
roups might be misleading: the FAIL group includes pa-
ients who died before they were able to be transferred to the
urgical department. When taking into account only the
urgically treated neonates, there is no significant difference
n mortality compared with the MED group, with only 4
ostoperative deaths, the last in 1991. Therefore mortality
oes not seem to be related to the surgical procedure itself
ut rather to the underlying disease and complications of
rematurity.
A larger PDA has been a significant predictor of high
ailure of indomethacin therapy.16 Our study supports these
esults in that prostaglandin synthetase inhibitors failed to
lose the PDA with larger diameters, indexed to the respec-
ive birth weight of the patient. Based on our findings, we
ropose an index, dividing the squared PDA diameter (in
quare millimeters) by the birth weight (in kilograms,
igure 1). Assuming a cutoff value of greater than 9
al closure,
 141)
Failed medical closure,
FAIL group (n  31) P value
20 (14) .001
) 11 (14.8) NS
) 100 (35.1) .01
) 69 (37.3) NS
us; NS, not significant.oups
medic
up (n
(7.2)
(13.2
(33.8
(33.1m2/kg, it is possible to correctly predict 41.5% of
ic and Cardiovascular Surgery ● Volume 135, Number 1 81
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Dedication failures that will eventually require surgical
ntervention, and only 12.5% of patients would inappro-
riately be sent directly to surgical intervention without a
edication trial that might have succeeded. Although the
tudy by Raval and colleagues15 also advocates earlier
DA ligation in unfavorable clinical settings, they found
imited predictive values of PDA size or chest radio-
raphic findings with regard to final outcome.
The limitations to this retrospective study covering 20
ears are inherent in the historical changes that have oc-
urred in neonatal care over time. Also, it is important to
tate that the timing of indomethacin initiation is essential to
he success rate of PDA closure (ie, the sooner, the better).
n our study it was not possible to retrieve this information
rom the charts, and better outcome rates could be expected
ith earlier initiation of medical treatment. This study only
ooked at the possibility of classical open surgery to further
reat a PDA after medication, and video-assisted thoraco-
copic surgery was not taken into account.
In conclusion, PDA closure is still achieved in a very
igh percentage of premature neonates with medical treat-
ent when the index of PDA diameter squared/birth weight
s less than 9 mm2/kg. In the absence of hemodynamic
nstability and contraindications to medication, it remains a
alid initial therapy. Patients with an index of greater than
mm2/kg would probably benefit from early direct surgical
losure without delay at the end of any given medical
rotocol, thus reducing preoperative assisted respiration
ime and intensive care unit stay, as well as reducing costs
rom overall shorter hospital stay. The effect of earlier
urgical intervention on oxygen dependence and chronic
ung disease remains to be studied, and further research is
equired to validate the accuracy of this index.
We thank Dr Walter Kistler and the Neonatology team of the
hildren’s Hospital of St Gallen, Switzerland, for the surgical
ssistance, referral, and perioperative care of some of the patients
resented in this series.
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